Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-10-06FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) filed by Organon LLC.
-
FDA approval · 2011-09-27FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium by Aurobindo Pharma Limited.
-
FDA approval · 2011-09-16FDA Approved: SIMVASTATIN — Original Application (Micro Labs Limited)
FDA approves Micro Labs Limited's original ANDA for simvastatin, a generic statin, enabling broader generic access in the U.S.
-
CLINICAL_TRIALS trial_result · 2011-09-14Clinical Trial Update: Short-term Changes on C-Reactive Protein (CRP) Levels After Non-surgical Periodontal Treatment [NA]
The study reports short-term changes in C-reactive protein levels after non-surgical periodontal treatment in participants with chronic peri…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation [Phase 4]
A Phase 4 study investigating heme oxygenase activity and adenosine-induced vasodilation in atherosclerotic cardiovascular disease has been …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-07-26FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy [Phase 4]
A Phase 4 clinical trial evaluated whether Coenzyme Q10 and selenium supplementation influence muscular adverse events in patients taking st…
-
FDA approval · 2011-06-17FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for LESCOL XL (fluvastatin sodium) submitted by Sandoz Inc.
-
FDA approval · 2011-06-16FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)
FDA approves a supplemental application for LIVALO (pitavastatin calcium) submitted by Kowa Pharmaceuticals America. The approval expands th…
-
CLINICAL_TRIALS research · 2011-05-12Clinical Trial Update: Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM) [Phase 2, Phase 3]
This clinical trial compares gastric bypass surgery versus best medical therapy to evaluate the progression of carotid intima-media thicknes…
-
FDA approval · 2011-02-22FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic simvastatin (SIMVASTATIN), enabling its marketing as a generic stati…
-
CLINICAL_TRIALS research · 2010-12-13Clinical Trial Update: Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy
This clinical trial investigates how genetic polymorphisms influence the lipid-lowering response to statin therapy.
-
FDA approval · 2010-09-20FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for simvastatin from Accord Healthcare, Inc. (ANDA 078155).
-
FDA approval · 2010-09-18FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC under ANDA077691. This action pertains to the appr…
-
FDA approval · 2010-09-08FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC. The approval indicates an approved modification to th…
-
FDA approval · 2010-06-01FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)
FDA approved a supplemental application for LIVALO (pitavastatin calcium) submitted by Kowa Pharmaceuticals America, Inc. The approval const…
-
FDA approval · 2010-05-03FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Lovastatin submitted by Carlsbad Technology, Inc.
-
FDA label_change · 2010-04-22FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC to update the product labeling.
-
FDA approval · 2010-04-08FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC. This action updates the product's labeling and…
-
FDA approval · 2010-03-10FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe/simvastatin) submitted by Organon LLC.
-
FDA approval · 2010-01-08FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Pravastatin Sodium (generic pravastatin) under the ANDA, authoriz…
-
FDA approval · 2009-11-06FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery
Clinical trial update regarding bridging therapy for patients at high risk of stent thrombosis undergoing surgery.
-
FDA approval · 2009-07-21FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-05-28Clinical Trial Update: Effect of Plant Stanol Ester-Containing Spread on Estimated Cardiovascular Risk in Comparison to Mediterranean Diet [Phase 4]
Phase 4 trial comparing plant stanol ester-containing spread to a Mediterranean diet for estimated cardiovascular risk in people with high c…